Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02396095 · ClinicalTrials.gov registry record
Oocyte Cryopreservation Study (Egg Banking)
A clinical trial, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- 24
- Enrollment target
NCT02396095: Clinical Trial study, sponsored by University of Pennsylvania.
NCT02396095 is a clinical trial that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02396095 was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- 24 participants
- Enrollment target
Study Summary
Women of reproductive age who seek to freeze eggs for future pregnancy attempts may be eligible to participate in a study investigating pregnancies that result from frozen eggs.
Primary Outcome
Live birthrate following transfer of embryos created from frozen eggs in the setting of: Autologous oocyte cryopreservation in women without cancer vs.autologous oocyte cryopreservation in women with cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-08 |
| Est. Completion | 2013-07 |
Why NCT02396095 stopped before completion
NCT02396095 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02396095 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02396095 about?
NCT02396095 is a clinical study titled "Oocyte Cryopreservation Study (Egg Banking)". Women of reproductive age who seek to freeze eggs for future pregnancy attempts may be eligible to participate in a study investigating pregnancies that result from frozen eggs.
What is the current status of trial NCT02396095?
This trial is currently terminated. The enrollment target is 24 participants. The study started on 2008-08. Estimated completion is 2013-07.
Who is sponsoring clinical trial NCT02396095?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia